Año: 2024
Journal Impact Factor (JIF): 9.60
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| CELL BIOLOGY | SCIE | 29/204 | Q1 | T1 | D2 |
Año: 2024
Journal Citation Indicator (JCI): 1,340
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| CELL BIOLOGY | 37/204 | Q1 | T1 | D2 | 82,11 |
Año:
2024
CiteScore:
15,400
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Cell Biology | 26/285 | Q1 | T1 | D1 |
| Cellular and Molecular Neuroscience | 7/100 | Q1 | T1 | D1 |
| Immunology | 23/240 | Q1 | T1 | D1 |
| Cancer Research | 24/233 | Q1 | T1 | D2 |
SJR año:
2024
Factor de Impacto:
2,773
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Cellular and Molecular Neuroscience | 9/100 | Q1 | T1 | D1 |
| Medicine (miscellaneous) | 96/2523 | Q1 | T1 | D1 |
| Cancer Research | 31/235 | Q1 | T1 | D2 |
| Cell Biology | 36/301 | Q1 | T1 | D2 |
| Immunology | 26/245 | Q1 | T1 | D2 |
| Agencia | Código de Proyecto |
|---|---|
| AECC (Spanish Association of Against Cancer) | GC16173720CARR |
| CIBER de Cancer | CB16/12/00275 |
| Consejeria de Salud | PI-0397-2017 |
| ERDF A way of making Europe | - |
| European Regional Development Fund (ERDF) from the Regional Ministry ofEconomic Transformation, Industry, Knowledge and Universities. Junta de Andalucia | - |
| European Union | - |
| Fundacion AECC | - |
| Fundacion BBVA | - |
| Japan Agency for Medical Research and Derevelopment | JP20bm0804022 |
| Junta de Andalucia | DOC_00512 |
| Leducq Foundation | 18CVD05 |
| MCIN/ AEI | RTI2018-097455-B-I00; PID2021-122629OB-I00 |
| The 2018 competitive research projects call within PAIDI 2020 | P18-RT-2501 |
| # | Autor | Afiliación |
|---|---|---|
| 1 | Otero-Albiol, D. | Hospital Universitario Virgen del Rocío; Instituto de Salud Carlos III (Spain) |
| 2 | Santos-Pereira, J. M. | Consejo Superior de Investigaciones Científicas (Spain) |
| 3 | Lucena-Cacace, A. | Center for iPS Cell Research and Application (Japan) |
| 4 | Clemente-González, C. | Hospital Universitario Virgen del Rocío; Instituto de Salud Carlos III (Spain) |
| 5 | Muñoz-Galvan, S. | Hospital Universitario Virgen del Rocío; Instituto de Salud Carlos III (Spain) |
| 6 | Yoshida, Y. | Center for iPS Cell Research and Application (Japan) |
| 7 | Hospital Universitario Virgen del Rocío; Instituto de Salud Carlos III (Spain) |